Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add filters

Document Type
Year range
1.
Public Health ; 206: 31-32, 2022 05.
Article in English | MEDLINE | ID: covidwho-1757764

Subject(s)
COVID-19 , Humans , SARS-CoV-2
2.
Public health ; 204:12-13, 2022.
Article in English | EuropePMC | ID: covidwho-1660561
3.
Public health ; 2022.
Article in English | EuropePMC | ID: covidwho-1678957
4.
Public Health ; 205: 26-27, 2022 04.
Article in English | MEDLINE | ID: covidwho-1649793
5.
Public Health ; 197: A1-A2, 2021 08.
Article in English | MEDLINE | ID: covidwho-1415743
6.
Public Health ; 198: 22-29, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1284483

ABSTRACT

OBJECTIVES: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - also known as the coronavirus disease (COVID-19) - pandemic has led to the swift introduction of population testing programmes in many countries across the world, using testing modalities such as drive-through, walk-through, mobile and home visiting programmes. Here, we provide an overview of the literature describing the experience of implementing population testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). STUDY DESIGN: Scoping review. METHODS: We conducted a scoping review using Embase, Medline and the Cochrane library in addition to a grey literature search. We identified indicators relevant to process, quality and resource outcomes related to each testing modality. RESULTS: In total, 2999 titles were identified from the academic literature and the grey literature search, of which 22 were relevant. Most studies were from the USA and the Republic of Korea. Drive-through testing centres were the most common testing modality evaluated and these provided a rapid method of testing whilst minimising resource use. CONCLUSIONS: The evidence base for population testing lacks high quality studies, however, the literature provides evaluations of the advantages and limitations of different testing modalities. There is a need for robust evidence in this area to ensure that testing is deployed in a safe and effective manner in response to the COVID-19 pandemic.


Subject(s)
COVID-19 , Pandemics , Humans , Republic of Korea , SARS-CoV-2
7.
J Public Health (Oxf) ; 44(1): e26-e35, 2022 Mar 07.
Article in English | MEDLINE | ID: covidwho-1284895

ABSTRACT

BACKGROUND: The impact of school closures/reopening on transmission of SARS-CoV-2 in the wider community remains contested. METHODS: Outbreak data from Colorado, USA (2020), alongside data on implemented public health measures were analyzed. RESULTS: There were three waves (n = 3169 outbreaks; 61 650 individuals). The first was led by healthcare settings, the second leisure/entertainment and the third workplaces followed by other settings where the trajectory was equally distributed amongst essential workplaces, non-essential workplaces, schools and non-essential healthcare.Non-acute healthcare, essential and non-essential workplace experienced more outbreaks compared to education, entertainment, large-group-living and social gatherings.Schools experienced 11% of identified outbreaks, yet involved just 4% of total cases. Conversely, adult-education outbreaks (2%) had disproportionately more cases (9%). CONCLUSION: Our findings suggest schools were not the key driver of the latest wave in infections. School re-opening coinciding with returning to work may have accounted for the parallel rise in outbreaks in those settings suggesting contact-points outside school being more likely to seed in-school outbreaks than contact points within school as the wave of outbreaks in all other settings occurred either prior to or simultaneously with the schools wave.School re-opening is a priority but requires mitigation measures to do so safely including staggering opening of different settings whilst maintaining low levels of community transmission.


Subject(s)
COVID-19 , COVID-19/epidemiology , Colorado/epidemiology , Disease Outbreaks , Humans , SARS-CoV-2 , Schools
8.
Public Health ; 196: A1-A2, 2021 07.
Article in English | MEDLINE | ID: covidwho-1201341
9.
Public Health ; 202: 10-11, 2022 01.
Article in English | MEDLINE | ID: covidwho-1057239
10.
Public Health ; 192: 45-48, 2021 03.
Article in English | MEDLINE | ID: covidwho-939208
11.
Public Health ; 187: A1-A2, 2020 10.
Article in English | MEDLINE | ID: covidwho-731887
12.
Public Health ; 185: A1-A2, 2020 08.
Article in English | MEDLINE | ID: covidwho-693082
13.
Public Health ; 186: A1-A2, 2020 09.
Article in English | MEDLINE | ID: covidwho-599385
SELECTION OF CITATIONS
SEARCH DETAIL